Chronic disease associated with bullous pemphigoid risk: A systematic review and meta-analysis

被引:0
作者
Siranart, Noppachai [1 ,2 ]
Chumpangern, Yanisa [3 ]
Phutinart, Somkiat [2 ]
Pajareya, Patavee [2 ]
Worapongpaiboon, Rinrada [2 ]
Winson, Chanissara [2 ]
Thongprayoon, Charat [1 ]
Cheungpasitporn, Wisit [1 ]
机构
[1] Mayo Clin, Dept Med, 200 1st St SW, Rochester, MN 55905 USA
[2] Chulalongkorn Univ, Dept Med, Bangkok, Thailand
[3] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Med, Bangkok, Thailand
来源
JAAD INTERNATIONAL | 2024年 / 17卷
关键词
bullous pemphigoid; chronic disease; mortality; risk; NEUROLOGICAL DISEASES; COMORBIDITY PROFILES; INPATIENT BURDEN; MORTALITY; DEATH; IMMUNOFLUORESCENCE; DIAGNOSIS;
D O I
10.1016/j.jdin.2024.08.010
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Bullous pemphigoid (BP) is a chronic autoimmune blistering disease prevalent in the elderly, often accompanied by renal comorbidities. Immune dysregulation can lead to secondary BP and increased mortality rates in those already diagnosed. Methods: A literature review identified studies on the association between kidney disease and other comorbidities with BP. Pooled effect estimates were analyzed utilizing a random-effects model. Objective: To assess comorbidity risks with BP and determine mortality risk among BP patients with comorbidities. Results: Analysis included 45,323 BP patients from 49 studies. Kidney diseases were significantly linked to higher BP incidence (subdistribution hazard ratio 1.51, 95% CI: 1.10-2.07) and increased mortality (hazard ratio 1.62, 95% CI: 1.13-2.32). Cerebrovascular diseases, dementia, and diabetes also showed significant associations with both increased BP incidence and mortality (P < .05). However, cardiovascular diseases and malignancy were only associated with increased mortality among BP patients (P < .001) without affecting BP incidence (P = .785 and P = .792, respectively). Limitation: The study comprises mostly case-control, prospective, and retrospective observational studies, alongside data heterogeneity. Conclusion: This study reveals the association of several chronic conditions, including kidney diseases, with BP, contributing to elevated mortality rates. The findings emphasize the importance of management targeting both BP and associated comorbidities to improve patient outcomes.
引用
收藏
页码:141 / 152
页数:12
相关论文
共 66 条
[1]   Clinical characteristics, mortality, and prognostic factors for bullous pemphigoid in a Thai population [J].
Amonchaisakda, Nuntouchaporn ;
Aiempanakit, Kumpol .
MEDICINE, 2020, 99 (43) :E22850
[2]   Risk Factors for Bullous Pemphigoid in the Elderly: A Prospective Case-Control Study [J].
Bastuji-Garin, Sylvie ;
Joly, Pascal ;
Lemordant, Pauline ;
Sparsa, Agnes ;
Bedane, Christophe ;
Delaporte, Emmanuel ;
Roujeau, Jean-Claude ;
Bernard, Philippe ;
Guillaume, Jean-Claude ;
Ingen-Housz-Oro, Saskia ;
Maillard, Herve ;
Pauwels, Catherine ;
Picard-Dahan, Catherine ;
Dutronc, Yes ;
Richard, Marie-Aleth .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2011, 131 (03) :637-643
[3]   Dipeptidyl peptidase IV inhibitors, a risk factor for bullous pemphigoid: Retrospective multicenter case-control study from France and Switzerland [J].
Benzaquen, Michael ;
Borradori, Luca ;
Berbis, Philippe ;
Cazzaniga, Simone ;
Valero, Rene ;
Richard, Marie-Aleth ;
Feldmeyer, Laurence .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 78 (06) :1090-1096
[4]   A population-based study of the association between bullous pemphigoid and neurologic disorders [J].
Brick, Katherine E. ;
Weaver, Chad H. ;
Savica, Rodolfo ;
Lohse, Christine M. ;
Pittelkow, Mark R. ;
Boeve, Bradley F. ;
Gibson, Lawrence E. ;
Camilleri, Michael J. ;
Wieland, Carilyn N. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 71 (06) :1191-1197
[5]   Mortality of bullous pemphigoid in Singapore: risk factors and causes of death in 359 patients seen at the National Skin Centre [J].
Cai, S. C. S. ;
Allen, J. C. ;
Lim, Y. L. ;
Chua, S. H. ;
Tan, S. H. ;
Tang, M. B. Y. .
BRITISH JOURNAL OF DERMATOLOGY, 2014, 170 (06) :1319-1326
[6]   Association Between Bullous Pemphigoid and Neurologic Diseases: A Case-Control Study [J].
Casas-de-la-Asuncion, E. ;
Ruano-Ruiz, J. ;
Rodriguez-Martin, A. M. ;
Velez Garcia-Nieto, A. ;
Moreno-Gimenez, J. C. .
ACTAS DERMO-SIFILIOGRAFICAS, 2014, 105 (09) :860-865
[7]   Diabetes mellitus and hyperglycemic complications in bullous pemphigoid [J].
Chai, Zi Teng ;
Tan, Colin ;
Liau, May MeiQi ;
Kaur, Harsharon ;
Pang, Shiu Ming ;
Phoon, Yee Wei ;
Chandran, Nisha Suyien ;
Lee, Haur Yueh .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 82 (05) :1234-1237
[8]   Cancer is not a risk factor for bullous pemphigoid: 10-year population-based cohort study [J].
Chen, C. T. ;
Hu, H. Y. ;
Chang, Y. T. ;
Li, C. P. ;
Wu, C. Y. .
BRITISH JOURNAL OF DERMATOLOGY, 2019, 180 (03) :553-558
[9]   Comorbidity profiles among patients with bullous pemphigoid: a nationwide population-based study [J].
Chen, Y. J. ;
Wu, C. Y. ;
Lin, M. W. ;
Chen, T. J. ;
Liao, K. K. ;
Chen, Y. C. ;
Hwang, C. Y. ;
Chu, S. Y. ;
Chen, C. C. ;
Lee, D. D. ;
Chang, Y. T. ;
Wang, W. J. ;
Liu, H. N. .
BRITISH JOURNAL OF DERMATOLOGY, 2011, 165 (03) :593-599
[10]   Neurological disorders in patients with bullous pemphigoid [J].
Cordel, Nadege ;
Chosidow, Olivier ;
Hellot, Marie-France ;
Delaporte, Emmanuel ;
Lok, Catherine ;
Vaillant, Loic ;
Bernard, Philippe ;
D'Incan, Michel ;
Roujeau, Jean Claude ;
Joly, Pascal .
DERMATOLOGY, 2007, 215 (03) :187-191